Characterization of the drugged human genome.
暂无分享,去创建一个
Albert Kriegner | Martin Lauss | Klemens Vierlinger | Christa Noehammer | M. Lauss | C. Noehammer | A. Kriegner | K. Vierlinger
[1] David E. Misek,et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.
[2] Bing Zhang,et al. WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..
[3] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[4] Kiyoko F. Aoki-Kinoshita,et al. From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..
[5] Robert D. Finn,et al. Pfam: clans, web tools and services , 2005, Nucleic Acids Res..
[6] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[7] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[8] J. Bonfield,et al. Finishing the euchromatic sequence of the human genome , 2004, Nature.
[9] T. Poggio,et al. Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.
[10] Janice M. Reichert,et al. Development trends for monoclonal antibody cancer therapeutics , 2007, Nature Reviews Drug Discovery.
[11] Y. Z. Chen,et al. Therapeutic Targets: Progress of Their Exploration and Investigation of Their Characteristics , 2006, Pharmacological Reviews.
[12] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[13] D. Conrad,et al. Global variation in copy number in the human genome , 2006, Nature.
[14] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[15] G. Glinsky,et al. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. , 2005, The Journal of clinical investigation.
[16] Gregory D. Schuler,et al. Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.
[17] Gavin D. Grant,et al. Common markers of proliferation , 2006, Nature Reviews Cancer.
[18] Alan F. Scott,et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2004, Nucleic Acids Res..
[19] P. Brown,et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[20] John J. Rossi,et al. Strategies for silencing human disease using RNA interference , 2007, Nature Reviews Genetics.
[21] R. Strausberg,et al. The Cancer Genome Anatomy Project: new resources for reading the molecular signatures of cancer , 2001, The Journal of pathology.
[22] D. Haussler,et al. Ultraconserved Elements in the Human Genome , 2004, Science.
[23] P. Imming,et al. Drugs, their targets and the nature and number of drug targets , 2006, Nature Reviews Drug Discovery.
[24] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[25] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.